GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » EPS (Diluted)

Wuxi AppTec Co (SHSE:603259) EPS (Diluted) : ¥3.24 (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co EPS (Diluted)?

Wuxi AppTec Co's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was ¥0.51. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥3.24.

Wuxi AppTec Co's EPS (Basic) for the three months ended in Dec. 2023 was ¥0.52. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥3.27.

Wuxi AppTec Co's EPS without NRI for the three months ended in Dec. 2023 was ¥0.60. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was ¥3.35.

During the past 12 months, Wuxi AppTec Co's average EPS without NRIGrowth Rate was 17.90% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 57.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 44.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Wuxi AppTec Co's highest 3-Year average EPS without NRI Growth Rate was 59.50% per year. The lowest was 11.30% per year. And the median was 41.20% per year.


Wuxi AppTec Co EPS (Diluted) Historical Data

The historical data trend for Wuxi AppTec Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co EPS (Diluted) Chart

Wuxi AppTec Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 1.05 1.73 2.82 3.24

Wuxi AppTec Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.72 1.07 0.94 0.51

Competitive Comparison of Wuxi AppTec Co's EPS (Diluted)

For the Diagnostics & Research subindustry, Wuxi AppTec Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's PE Ratio falls into.



Wuxi AppTec Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Wuxi AppTec Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(9606.749-0)/2965.046
=3.24

Wuxi AppTec Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1530.342-0)/2985.011
=0.51

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuxi AppTec Co  (SHSE:603259) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Wuxi AppTec Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co (SHSE:603259) Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.

Wuxi AppTec Co (SHSE:603259) Headlines

No Headlines